Navigation Links
Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market
Date:5/22/2008

Japanese Distributor to Expand Global Reach of Novel Technology

N. BILLERICA, Mass., May 22 /PRNewswire/ -- Seahorse Bioscience, leaders in real-time measurement of cellular bioenergetics, announced today that Primetech Corporation will become the exclusive supplier of Seahorse XF instruments and consumables in Japan.

"Japan's contribution to research and drug discovery is continuing to grow, as we have seen with the recent acquisition of Millennium by Takeda Pharmaceutical Company and with its increasing pipeline of new drugs in development," Mr. Ryosuke Ogihara, CEO of Primetech Corporation said. "Our customers are interested in studying mitochondrial dysfunction, and in particular its role in cancer, obesity and age-related diseases. Seahorse XF instruments offer the only practical way to study mitochondria in whole cells."

Introduced in June of 2006, Seahorse extracellular flux (XF) analyzers provide the first and only method to non-invasively measure the two major energy producing pathways -- mitochondrial respiration and glycolysis -- in living cells. The microplate-based technology allows scientists to assess the impact of drugs, genetic modifications and environment by monitoring the rate that cells consume oxygen and produce metabolic byproducts including acid and carbon dioxide.

"With a now well-established base of users in North America, we are expanding our reach to academic, biotech and pharma customers throughout the world" said Steve Chomicz, Vice President of Sales and Marketing at Seahorse. "We have chosen to work with Primetech after seeing their commitment to supporting their customers- an important factor in the introduction of innovative research instrumentation."

About Seahorse Bioscience, Inc.

Seahorse Bioscience is changing cancer, obesity, diabetes and age-related drug discovery programs the world over. Seahorse headquarters are located in North Billerica, Massachusetts. For more information, please visit http://www.seahorsebio.com.

About Primetech Corporation

For more than 15 years, Primetech Corporation has been a manufacturer and distributor of high technology medical and analytical science products throughout Japan. Primetech's focus on medical and analytical science products, a technically advanced staff, and an intimate knowledge of the Japanese marketplace allow it to assist companies in penetrating the Japanese market.

If you would like more information about Seahorse Bioscience, Inc., or would like to schedule a meeting with Steve Chomicz, please contact Kristine Hunt at 978-671-1610.


'/>"/>
SOURCE Seahorse Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ardea Biosciences Announces Upcoming Corporate Meetings
2. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
3. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
4. Pressure BioSciences, Inc. Announces Move to New Corporate Offices
5. Numira Biosciences Names New Board Member
6. DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
7. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
8. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
9. Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
10. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
11. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing ... the results of a simple test will take days to arrive to the end ... offers customers direct access to their lab tests, bypassing the cost and delay of ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Seamild, the ... on the futuristic vision of its owner and founder. As Oat is recognized globally ... to everybody he knows personally as he believes it is a move to sow ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... its new medical office in Petaluma, located at 167 Lynch Creek Way. The ... to SRO sports medicine and rehabilitation services and on-site x-ray services. ...
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® and Roadie, ... use or need, from clothes to couches to dressers and bicycles. Roadie — the ... to the nearest Goodwill donation center through February 28th. , “January is an ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 Many patients don,t realize that they ... a pharmacy just a few blocks away charges only ... problem Medicationdiscountcard.com has created a price comparison ... much their medication will cost at most nearby pharmacies. ... Medicationdiscountcard.com takes all of the ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 Agonists, ... Others The global anti-obesity drugs market is ... half of the forecast period and CAGR of 38.7% in the ... grow at a CAGR of 32.8% from 2016 to 2027. The ... 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
Breaking Medicine Technology: